Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
*Updated 2022: Allergan is now part of AbbVie
We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy.
AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech.
Since the beginning, our mission hasn’t wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers.